倚天屠龙记

公益福彩亮相武威公交车_我的网站

A |     城市温情，藏于街巷日常；善意风尚，贵在润物无声。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。近日，公益福彩公交车体广告亮相甘肃武威街头，穿梭在凉州大地，将温润向善的福彩文化融入城市脉络，化作流动的城市文明风景线，让公益善意悄然浸润街头巷尾、千家万户。依托公交全域穿行、覆盖广泛的独特优势，公交车体广告在传播“公益、慈善、健康、快乐、创新”福彩文化的同时，也让广大市民进一步了解福彩、关注福彩，以流动载体承载公益初心，凝聚社会向善力量。微小善意，可聚满城温度；寻常坚守，方显公益初心。此次车体广告投放，是武威福彩拓宽宣传渠道、丰富传播维度的一次实践探索。近年来，武威市福彩中心立足城市特色、贴近群众生活，持续搭建全方位公益宣传格局：线上构建电视、广播、新媒体全方位立体化全媒体传播矩阵；线下依托交通载体、户外电子显示屏、商圈点位、乡镇宣传栏协同发力，精心打造天马湖沿岸围栏公益长廊，将福彩理念与滨湖风光相融，在人流密集广场设置遮阳休息座椅等，形成线上线下联动、静态动态互补的完整传播链条，让福彩善意融入城市每一处角落。

B |

Current article:http://i6f.chuandanfozhuanbenglipaicuzi.pics/0k51jqc/20260826/436321.html

Published on:09:47:22